The role of cyano-phycocyanin as a quorum sensing inhibitor to attenuate Pseudomonas aeruginosa virulence
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1624927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Jun Ying und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Quorum Sensing, Pseudomonas aeruginosa, Phycocyanin, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
In recent years, developing drugs that directly target pathways related to the pathogenic mechanisms of bacteria has been a research hotspot, and quorum sensing (QS) is one of the most effective strategies to combat multidrug-resistant bacteria. We evaluated the inhibitory effect of cyano-phycocyanin (C-PC) on the virulence of PA2 in vitro and in vivo and explored its potential as a quorum sensing inhibitor (QSI).
Methods
In this study, the minimum inhibitory concentration (MIC) and growth curve of C-PC on PA2 were determined, and the effect of C-PC on QS-regulated virulence factors and the anti-biofilm activity of C-PC against PA2 were investigated. The Pseudomonas quinolone signal (PQS) were analyzed by HPLC system and the expression levels of QS signaling molecules, virulence genes, biofilm and movement-related genes were detected by qPCR. The macrophage and mouse infection model were used to explore the anti-infection ability of C-PC in vitro and in vivo .
Results
C-PC attenuated biofilm formation, pyocyanin synthesis, motility, and PQS signaling molecule production. Moreover, C-PC significantly downregulated the transcription levels of QS-related genes in PA2, including pqsA and pqsR , as well as the expression of virulence factor genes phzA , lasA , lasB , flgF , fliE , exoS , exsA , lecA , popB , vasG , chiC , pelF , pslB , qseB , and pgsR . In vitro , C-PC reduced the adhesion and invasion of PA2 in RAW264.7 cells, and decreased LDH release and macrophage damage caused by PA2 infection. In vivo , C-PC reduced the pathogenicity of PA2 and improved mouse survival rates, showing a protective effect.
Conclusion
Taken together, these results suggest that C-PC showed strong anti-QS activity, providing new insights into the development of strategies against PA infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.
- Wenzhou Semir United International School, Wenzhou, China.
- Rehabilitation Medicine, No.906 Hospital of Joint Logistic Support Force of PLA, Wenzhou, China.
- Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou, China.
Zitieren
APA
Ying, J., Guo, S., Pan, Y., Li, D., Tai, Y., Li, Y., Lin, Q., Pan, L., Huang, D., Xiao, H., Pan, R., Xu, X., Xie, J., Lou, Z., & Li, P. (2025). The role of cyano-phycocyanin as a quorum sensing inhibitor to attenuate Pseudomonas aeruginosa virulence. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1624927
Vancouver
Ying J, Guo S, Pan Y, Li D, Tai Y, Li Y, et al. The role of cyano-phycocyanin as a quorum sensing inhibitor to attenuate Pseudomonas aeruginosa virulence. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1624927
BibTeX
@article{Ying2025,
author = {Ying, Jun and Guo, Shiqun and Pan, Yunru and Li, Dong and Tai, Yijia and Li, Yue and Lin, Qinyu and Pan, Lingling and Huang, Dadao and Xiao, Hanqi and Pan, Ruowang and Xu, Xiaomin and Xie, Jing and Lou, Zhefeng and Li, Peizhen},
title = {The role of cyano-phycocyanin as a quorum sensing inhibitor to attenuate Pseudomonas aeruginosa virulence},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1624927}
}
EUVIMED